Your browser doesn't support javascript.
loading
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.
Giaccherini, Cinzia; Marchetti, Marina; Masci, Giovanna; Verzeroli, Cristina; Russo, Laura; Celio, Luigi; Sarmiento, Roberta; Gamba, Sara; Tartari, Carmen J; Diani, Erika; Vignoli, Alfonso; Malighetti, Paolo; Spinelli, Daniele; Tondini, Carlo; Barni, Sandro; Giuliani, Francesco; Petrelli, Fausto; D'Alessio, Andrea; Gasparini, Giampietro; De Braud, Filippo; Santoro, Armando; Labianca, Roberto; Falanga, Anna.
Afiliação
  • Giaccherini C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Marchetti M; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Masci G; Oncology Unit, IRCCS Humanitas Institute, Rozzano.
  • Verzeroli C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Russo L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Celio L; Oncology Unit, IRCCS National Cancer Institute, Milan.
  • Sarmiento R; Oncology Unit, Hospital San Filippo Neri, Rome.
  • Gamba S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Tartari CJ; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Diani E; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Vignoli A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo.
  • Malighetti P; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo.
  • Spinelli D; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo.
  • Tondini C; Oncology Unit, Hospital Papa Giovanni XXIII, Bergamo.
  • Barni S; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio.
  • Giuliani F; Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, Bari.
  • Petrelli F; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio.
  • D'Alessio A; Medical Oncology and Internal Medicine, Policlinico San Marco, Zingonia-Bergamo.
  • Gasparini G; Oncology Unit, Hospital San Filippo Neri, Rome.
  • De Braud F; Oncology Unit, IRCCS National Cancer Institute, Milan.
  • Santoro A; Oncology Unit, IRCCS Humanitas Institute, Rozzano.
  • Labianca R; Department Oncology Bergamo Province, Hospital Papa Giovanni XXIII, Bergamo.
  • Falanga A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo annafalanga@yahoo.com.
Haematologica ; 105(6): 1704-1711, 2020 06.
Article em En | MEDLINE | ID: mdl-31558668
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article